LAKE FOREST, Ill.--(BUSINESS WIRE)--New data on Sirtex’s SIR-Spheres® microspheres will be presented at the 2007 American Society of Clinical Oncology (ASCO) Gastrointestinal Symposium. The meeting will be held Jan. 19-21 at the Orlando World Center Marriott in Orlando, Fla. Andrew Kennedy, M.D., F.A.C.R.O., co-medical director of Wake Radiology Oncology in Cary, N.C., will present a poster session reporting the findings of a new retrospective analysis evaluating liver tolerance to repeated doses of radiation from SIR-Spheres microspheres (90Y-microspheres). Sirtex’s SIR-Spheres microspheres are the only FDA-approved microsphere therapy for liver tumors that originate in the colon or rectum.
